Cargando…
Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss
BACKGROUND: PTEN loss contributes to the development of liver diseases including hepatic steatosis and both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The factors that influence the penetrance of these conditions are unclear. We explored the influence of sustained hypoxia signaling...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383253/ https://www.ncbi.nlm.nih.gov/pubmed/25844041 http://dx.doi.org/10.2147/GICTT.S72274 |
_version_ | 1782364702789074944 |
---|---|
author | Sendor, Adam B Hacker, Kathryn E Chen, Shufen Corona, Armando L Sen, Oishee Chiang, Derek Y Snavely, Anna Rogers, Arlin B Montgomery, Stephanie A Rathmell, W Kimryn McRee, Autumn J |
author_facet | Sendor, Adam B Hacker, Kathryn E Chen, Shufen Corona, Armando L Sen, Oishee Chiang, Derek Y Snavely, Anna Rogers, Arlin B Montgomery, Stephanie A Rathmell, W Kimryn McRee, Autumn J |
author_sort | Sendor, Adam B |
collection | PubMed |
description | BACKGROUND: PTEN loss contributes to the development of liver diseases including hepatic steatosis and both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The factors that influence the penetrance of these conditions are unclear. We explored the influence of sustained hypoxia signaling through co-deletion of Pten and Vhl in a murine model. METHODS: We used a CreER-linked Keratin 18 mouse model to conditionally delete Pten, Vhl or both in somatic cells of adult mice, evaluating the resultant tumors by histology and gene expression microarray. Existing sets of gene expression data for human HCC and CC were examined for pathways related to those observed in the murine tumors, and a cohort of human CC samples was evaluated for relationships between HIF-1α expression and clinical outcomes. RESULTS: Both Pten deletion genotypes developed liver tumors, but with differing phenotypes. Pten deletion alone led to large hepatic tumors with widespread hepatosteatosis. Co-deletion of Pten and Vhl with the Keratin 18 promoter resulted in reduced steatosis and a reduced tumor burden that was characterized by a trabecular architecture similar to CC. Genes associated with hepatic steatosis were coordinately expressed in the human HCC dataset, while genes involved in hypoxia response were upregulated in tumors from the human CC dataset. HIF-1α expression and overall survival were examined in an independent cohort of human CC tumors with no statistical differences uncovered. CONCLUSION: Pten deletion in Keratin 18 expressing cells leads to aggressive tumor formation and widespread steatosis in mouse livers. Co-deletion of Vhl and Pten results in lower tumor burden with gene expression profiling suggesting a switch from a profile of lipid deposition to an expression profile more consistent with upregulation of the hypoxia response pathway. A relationship between tumor hypoxia signaling and altered hepatic steatotic response suggests that competing influences may alter tumor phenotypes. |
format | Online Article Text |
id | pubmed-4383253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
record_format | MEDLINE/PubMed |
spelling | pubmed-43832532015-04-02 Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss Sendor, Adam B Hacker, Kathryn E Chen, Shufen Corona, Armando L Sen, Oishee Chiang, Derek Y Snavely, Anna Rogers, Arlin B Montgomery, Stephanie A Rathmell, W Kimryn McRee, Autumn J Gastrointest Cancer Article BACKGROUND: PTEN loss contributes to the development of liver diseases including hepatic steatosis and both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The factors that influence the penetrance of these conditions are unclear. We explored the influence of sustained hypoxia signaling through co-deletion of Pten and Vhl in a murine model. METHODS: We used a CreER-linked Keratin 18 mouse model to conditionally delete Pten, Vhl or both in somatic cells of adult mice, evaluating the resultant tumors by histology and gene expression microarray. Existing sets of gene expression data for human HCC and CC were examined for pathways related to those observed in the murine tumors, and a cohort of human CC samples was evaluated for relationships between HIF-1α expression and clinical outcomes. RESULTS: Both Pten deletion genotypes developed liver tumors, but with differing phenotypes. Pten deletion alone led to large hepatic tumors with widespread hepatosteatosis. Co-deletion of Pten and Vhl with the Keratin 18 promoter resulted in reduced steatosis and a reduced tumor burden that was characterized by a trabecular architecture similar to CC. Genes associated with hepatic steatosis were coordinately expressed in the human HCC dataset, while genes involved in hypoxia response were upregulated in tumors from the human CC dataset. HIF-1α expression and overall survival were examined in an independent cohort of human CC tumors with no statistical differences uncovered. CONCLUSION: Pten deletion in Keratin 18 expressing cells leads to aggressive tumor formation and widespread steatosis in mouse livers. Co-deletion of Vhl and Pten results in lower tumor burden with gene expression profiling suggesting a switch from a profile of lipid deposition to an expression profile more consistent with upregulation of the hypoxia response pathway. A relationship between tumor hypoxia signaling and altered hepatic steatotic response suggests that competing influences may alter tumor phenotypes. 2015-02-01 /pmc/articles/PMC4383253/ /pubmed/25844041 http://dx.doi.org/10.2147/GICTT.S72274 Text en © 2015 Sendor et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) http://dx.doi.org/10.2147/GICTT.S72274 License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php |
spellingShingle | Article Sendor, Adam B Hacker, Kathryn E Chen, Shufen Corona, Armando L Sen, Oishee Chiang, Derek Y Snavely, Anna Rogers, Arlin B Montgomery, Stephanie A Rathmell, W Kimryn McRee, Autumn J Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss |
title | Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss |
title_full | Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss |
title_fullStr | Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss |
title_full_unstemmed | Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss |
title_short | Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss |
title_sort | von hippel-lindau status influences phenotype of liver cancers arising from pten loss |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383253/ https://www.ncbi.nlm.nih.gov/pubmed/25844041 http://dx.doi.org/10.2147/GICTT.S72274 |
work_keys_str_mv | AT sendoradamb vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT hackerkathryne vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT chenshufen vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT coronaarmandol vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT senoishee vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT chiangdereky vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT snavelyanna vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT rogersarlinb vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT montgomerystephaniea vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT rathmellwkimryn vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss AT mcreeautumnj vonhippellindaustatusinfluencesphenotypeoflivercancersarisingfromptenloss |